All Stories

'Patently illegal': NIH and HHS face new lawsuit over $...

The American Public Health Association and several researchers are suing the NIH...

‘Patently illegal’: NIH and HHS face new lawsuit over $...

The American Public Health Association and several researchers are suing the NIH...

Cerevance fails phase 2 trial in early, untreated Parki...

Cerevance’s attempt to unlock the first-line Parkinson's disease market has hit ...

British biotech CellCentric expands to Boston with plan...

British biotech CellCentric is settling into a new office in Boston, part of the...

Princeton and Harvard join other Ivy League schools fac...

The Trump administration is halting research funding to Princeton University and...

Medtronic inks stroke AI partnership with European deve...

The medtech giant plans to integrate Methinks AI’s apps with its portfolio of is...

Medtronic inks stroke AI partnership with European deve...

The medtech giant plans to integrate Methinks AI’s apps with its portfolio of is...

CMR Surgical nets $200M to support Versius robot’s US l...

Following the FDA clearance of its Versius robot last fall, CMR Surgical has rai...

FDA’s Chief Medical Officer Hilary Marston is out amid ...

The FDA’s Chief Medical Officer Hilary Marston, M.D., is leaving her position at...

FDA’s Chief Medical Officer Hilary Marston is out mid m...

The FDA’s Chief Medical Officer Hilary Marston, M.D., is leaving her position at...

Fierce Biotech Fundraising Tracker '25: Atsena adds $15...

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...

Sanofi taps Nurix for pipeline nourishment once again, ...

Sanofi has returned to Nurix Therapeutics for another autoimmune candidate, payi...

Edgewise claims heart valve pressure benefits in phase ...

Edgewise Therapeutics' hypertrophic cardiomyopathy asset has resulted in “rapid ...

Atsena raises $150M for ocular gene therapies with Bain...

Atsena Therapeutics has raised $150 million in an oversubscribed series C financ...

Patient suffers side effect in Cabaletta autoimmune CAR...

Analysts appeared unfazed by the news that a patient treated with Cabaletta Bio’...

Federal judge blocks FDA's regulation of lab-developed ...

The ruling was issued for a pair of lawsuits brought against the FDA by the Amer...

2 investment firms secure large stakes in Novotech

Two investment firms have acquired large stakes in global CRO Novotech, the Sing...

Merck KGaA pays $85M to nab global rights for Abbisko's...

With the CSF-1R inhibitor space heating up, Merck KGaA has gone all-in on pimico...

Fierce Biotech Layoff Tracker 2025: Sail cuts staff; Ca...

As always, if you know of layoffs occurring at a biotech, please reach out to th...

Flagship-backed Sail Biomedicines lays off staff follow...

Flagship Pioneering-backed Sail Biomedicines has laid off 12 employees following...

AstraZeneca, Memorial Sloan Kettering adopt tech firm's...

AstraZeneca and the Memorial Sloan Kettering Cancer Center have tapped digital h...

SynCardia artificial heart maker Picard Medical plans t...

Picard Medical, which owns and operates the implant manufacturer SynCardia, aims...

Federal judge blocks FDA’s regulation of lab-developed ...

The ruling was issued for a pair of lawsuits brought against the FDA by the Amer...

After Eric Green's exit, new leader of NIH's genome res...

Vence Bonham Jr., the highest ranking official at the National Human Genome Rese...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.